Lindqvist et al identified risk factors associated with venous thromboembolism (VTE) in women during the postpartum period. Appropriate management depends on the level of risk. The authors are from Malmo University, Lund University and Karolinska Hospital in Sweden.
Condition |
Modifier |
Risk Level |
---|---|---|
Factor V Leiden |
heterozygous |
1 |
Factor V Leiden |
homozygous |
3 |
prothrombin gene mutation |
heterozygous |
1 |
prothrombin gene mutation |
homozygous |
3 |
overweight in early pregnancy |
BMI > 28 k per sq m |
1 |
cesarean section |
|
1 |
family history of thrombosis in a first degree relative < 60 years of age |
|
1 |
age > 40 |
|
1 |
pre-eclampsia |
|
1 |
abruptio placenta |
|
1 |
protein S deficiency |
|
2 |
protein C deficiency |
|
2 |
immobilization |
>= 1 week |
2 |
lupus anticoagulant |
|
2 |
cardiolipin antibodies |
|
2 |
history of previous venous thrombo-embolic event (VTE) |
|
4 |
history of repeated VTE |
|
5 |
antiphospholipid syndrome (APS) |
without prior VTE |
4 |
antiphospholipid syndrome (APS) |
with prior VTE |
5 |
mechanical heart valve |
|
5 |
need for continuous warfarin prophylaxis |
|
5 |
antithrombin deficiency |
|
5 |
other risk factor |
|
1 |
Risk Level |
Risk Relative to Pregnancy |
Management |
---|---|---|
0 |
none |
none |
1 |
5-fold increase |
none |
2 |
25 fold increase |
short term (7 days) low molecular weight heparin after delivery or if immobilized |
3 |
125 fold increase |
6 week low molecular weight heparin starting within 4 hours after delivery |
4 |
high (10% absolute) |
antepartum prophylaxis AND continuing >= 6 weeks of low molecular weight heparin after delivery |
5 |
very high (> 15% absolute) |
high dose antepartum prophylaxis AND >= 12 weeks of low molecular weight heparin after delivery |
Additional recommendations:
(1) A woman with antiphospholipid syndrome, lupus anticoagulant, or anticardiolipin antibody should receive ASA 75 mg/d (low dose).
(2) Factor-Xa monitoring should be performed for very high risk patients.
(3) Antepartum therapy for high risk patients is started during the second trimester.
(4) Antepartum therapy for very high risk patients is started as soon as possible, sometimes preceding the pregnancy.
Purpose: To identify a woman at risk for venous thromboembolism (VTE) during pregnancy using the risk score of Lindqvist et al.
Specialty: Hematology Oncology, Clinical Laboratory
Objective: risk factors, severity, prognosis, stage
ICD-10: O22, O87,